"If we do our jobs right, and you come back a year from now, this place is going to be a buzzing hive" -- Vertex Executive ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 ...
Vertex Flare is an online crypto trading platform designed using the latest technologies like artificial intelligence and ...
Zacks.com on MSN22h
Vertex to Report Q4 Earnings: What's in Store for the Stock?Vertex, Inc. VERX is scheduled to report fourth-quarter 2024 results before market open on Feb. 27. Find the latest EPS ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Read about a $100 million single-award IDIQ contract awarded by the FBI to Vertex Aerospace for aviation maintenance support ...
On its pricing page, the tech giant has now detailed what it will charge its Vertex AI users to access its video generation ...
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.82% to $480.33 Thursday, on what proved to be an all-around grim trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback